ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
Synthesis of an Enzyme-Triggered Chitosan-Based Drug Delivery System for Peri-Implantitis Prevention.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Dental implants have become a leading solution for tooth loss, yet bacterial infections remain a major complication. Antibacterial implant coatings are an important approach to reduce or prevent bacterial infections at the implant. Given the oral cavity's complex microbiome and the importance of some commensal bacteria, it is crucial to develop antibacterial implant coatings that release the active ingredient only when needed. In this work, an enzyme-triggered drug delivery coating based on chitosan with ciprofloxacin as antibiotic was synthesized. The ciprofloxacin is covalently bound via a self-immolative linker with an enzyme-labile group. The linker-drug conjugate was bound to modified chitosan through a Diels-Alder click reaction. A stable drug-delivering coating was assembled on titanium by alternating cationic chitosan with the drug with anionic alginate using layer-by-layer dip-coating. Ellipsometry was used to characterize the coating and demonstrating its stability. The function of the enzyme-labile self-immolative linker was clearly demonstrated by release experiments and detection of genuine ciprofloxacin using UHPLC/HRAM-MS and MS/MS. Furthermore, its biocompatibility was confirmed. After enzymatic activation, the coating exhibited antibacterial activity against an A. naeslundii biofilm. This provides proof of principle for this enzyme-responsive approach to drug delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.